BioCentury | Oct 3, 2019
Finance

Tenaya to deploy $92M series B to develop heart disease platforms in parallel

...studies as soon as late 2021, CEO Faraz Ali told BioCentury. Nearly three years after Tenaya Therapeutics Inc....
...on a potential listing as well, although Tenaya could raise another private round. Paul Bonanos, Associate Editor Tenaya Therapeutics Inc. heart...
BioCentury | Jun 27, 2019
Product Development

Gene therapy’s next frontier lies beyond rare, monogenic diseases

...Manufacturing Into Its Own Hands” ). While industry may not have the manufacturing capacity yet, Tenaya Therapeutics Inc....
...there are populations of Japanese patients with loss-of-function mutations in C9 that live healthy lives. Tenaya Therapeutics Inc....
...Inc. (NASDAQ:REGN), Tarrytown, N.Y. RegenxBio Inc. (NASDAQ:RGNX), Rockville, Md. Spark Therapeutics Inc. (NASDAQ:ONCE), Philadelphia, Penn. Tenaya Therapeutics Inc....
BioCentury | Mar 14, 2019
Company News

Management tracks: Sandoz CEO steps down, C4T hires NIBR's Crystal as CMO

...Ball as CEO. Ball was global VP commercial, informatics at Illumina Inc. (NASDAQ:ILMN). Cardiovascular company Tenaya Therapeutics Inc....
...Biotherapeutics Inc., which PTC Therapeutics Inc. (NASDAQ:PTCT) acquired. Sandi Wong, Staff Writer C4 Therapeutics Inc. Contextual Genomics Inc. Novartis AG Sandoz Tenaya Therapeutics Inc....
BioCentury | Aug 3, 2018
Company News

Management tracks: Cellectis, Navitor

...AG (NYSE:NVS; SIX:NOVN), where he headed the company's immuno-oncology and targeted therapy portfolios. Cardiovascular company Tenaya Therapeutics Inc....
BioCentury | Nov 11, 2017
Finance

Extending Exonics

...neuromuscular disorders beyond DMD. Other recent academic spinouts backed by TCG include regenerative medicine companies Tenaya Therapeutics Inc....
BioCentury | Nov 2, 2017
Company News

Management tracks: Melinta, Lundbeck

...marketing therapy leader for the glaucoma portfolio at Santen Pharmaceutical Co. Ltd. (Tokyo:4536). Cardiovascular company Tenaya Therapeutics Inc....
BioCentury | Feb 23, 2017
Finance

Surrogate Wnts

...2, 2016) . In December, the VC led a $50 million series A round for Tenaya Therapeutics Inc....
BioCentury | Jan 27, 2017
Emerging Company Profile

Cardiac conversion

...are beginning to report positive clinical data, but they require frequent administration via invasive procedures. Tenaya Therapeutics Inc....
...mutant cardiomyocytes to discover small molecules to treat cardiomyopathy. Details are not disclosed. COMPANY PROFILE Tenaya Therapeutics Inc....
...Undisclosed Companies and Institutions Mentioned Gladstone Institutes, San Francisco, Calif. Juventas Therapeutics Inc., Cleveland, Ohio Tenaya Therapeutics Inc....
BioCentury | Dec 14, 2016
Finance

Building Tenaya

...As the only non-angel investor in cardiovascular company Tenaya Therapeutics Inc. ’s $50 million series A round, The...
...the sole investor in the regenerative medicine company, but declined to disclose details. -Virginia Li Virginia Li Tenaya Therapeutics Inc. The...
BioCentury | Dec 9, 2016
Financial News

Tenaya completes venture financing

...round led by The Column Group. Angel investors also participated. Tenaya Therapeutics Inc. , San Francisco, Calif. Alex Himes Tenaya Therapeutics Inc....
Items per page:
1 - 10 of 11
BioCentury | Oct 3, 2019
Finance

Tenaya to deploy $92M series B to develop heart disease platforms in parallel

...studies as soon as late 2021, CEO Faraz Ali told BioCentury. Nearly three years after Tenaya Therapeutics Inc....
...on a potential listing as well, although Tenaya could raise another private round. Paul Bonanos, Associate Editor Tenaya Therapeutics Inc. heart...
BioCentury | Jun 27, 2019
Product Development

Gene therapy’s next frontier lies beyond rare, monogenic diseases

...Manufacturing Into Its Own Hands” ). While industry may not have the manufacturing capacity yet, Tenaya Therapeutics Inc....
...there are populations of Japanese patients with loss-of-function mutations in C9 that live healthy lives. Tenaya Therapeutics Inc....
...Inc. (NASDAQ:REGN), Tarrytown, N.Y. RegenxBio Inc. (NASDAQ:RGNX), Rockville, Md. Spark Therapeutics Inc. (NASDAQ:ONCE), Philadelphia, Penn. Tenaya Therapeutics Inc....
BioCentury | Mar 14, 2019
Company News

Management tracks: Sandoz CEO steps down, C4T hires NIBR's Crystal as CMO

...Ball as CEO. Ball was global VP commercial, informatics at Illumina Inc. (NASDAQ:ILMN). Cardiovascular company Tenaya Therapeutics Inc....
...Biotherapeutics Inc., which PTC Therapeutics Inc. (NASDAQ:PTCT) acquired. Sandi Wong, Staff Writer C4 Therapeutics Inc. Contextual Genomics Inc. Novartis AG Sandoz Tenaya Therapeutics Inc....
BioCentury | Aug 3, 2018
Company News

Management tracks: Cellectis, Navitor

...AG (NYSE:NVS; SIX:NOVN), where he headed the company's immuno-oncology and targeted therapy portfolios. Cardiovascular company Tenaya Therapeutics Inc....
BioCentury | Nov 11, 2017
Finance

Extending Exonics

...neuromuscular disorders beyond DMD. Other recent academic spinouts backed by TCG include regenerative medicine companies Tenaya Therapeutics Inc....
BioCentury | Nov 2, 2017
Company News

Management tracks: Melinta, Lundbeck

...marketing therapy leader for the glaucoma portfolio at Santen Pharmaceutical Co. Ltd. (Tokyo:4536). Cardiovascular company Tenaya Therapeutics Inc....
BioCentury | Feb 23, 2017
Finance

Surrogate Wnts

...2, 2016) . In December, the VC led a $50 million series A round for Tenaya Therapeutics Inc....
BioCentury | Jan 27, 2017
Emerging Company Profile

Cardiac conversion

...are beginning to report positive clinical data, but they require frequent administration via invasive procedures. Tenaya Therapeutics Inc....
...mutant cardiomyocytes to discover small molecules to treat cardiomyopathy. Details are not disclosed. COMPANY PROFILE Tenaya Therapeutics Inc....
...Undisclosed Companies and Institutions Mentioned Gladstone Institutes, San Francisco, Calif. Juventas Therapeutics Inc., Cleveland, Ohio Tenaya Therapeutics Inc....
BioCentury | Dec 14, 2016
Finance

Building Tenaya

...As the only non-angel investor in cardiovascular company Tenaya Therapeutics Inc. ’s $50 million series A round, The...
...the sole investor in the regenerative medicine company, but declined to disclose details. -Virginia Li Virginia Li Tenaya Therapeutics Inc. The...
BioCentury | Dec 9, 2016
Financial News

Tenaya completes venture financing

...round led by The Column Group. Angel investors also participated. Tenaya Therapeutics Inc. , San Francisco, Calif. Alex Himes Tenaya Therapeutics Inc....
Items per page:
1 - 10 of 11